Asthma, pneumonia and over 20 other conditions affecting the lungs and respiratory system are supported by PIP.

A single charge lasts for 35 minutes of use, and the unit only needs to be recharged once every two days. Pharmacy students ...

Explore the latest research on Aspergillus in bronchiectasis, uncovering its prevalence, clinical significance, and potential ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into ...

The perspectives and priorities of people living with chronic obstructive pulmonary disease (COPD) should be integrated into the development process of new therapies for COPD, according to a new ...

The NCFB market in the 7 Major Markets was valued at approximately USD 1.45 billion in 2023. Over the forecast period from 2024 to 2034, this market is projected to grow at a CAGR of 14.5%.Dublin, Dec ...

The "Non-cystic fibrosis bronchiectasis - Pipeline Insight, 2024" report has been added to ResearchAndMarkets.com's offering.The latest comprehensive report on Non-cystic Fibrosis Bronchiectasis (NCFB ...

A new way of treating serious asthma and chronic obstructive pulmonary disease (COPD) attacks could be a "game-changer" and lead to the first leap in treatment for 50 years, researchers have said.

Benralizumab is a monoclonal antibody that targets specific white blood cells, called eosinophils, to reduce lung inflammation. It is currently used as a repeat treatment for severe asthma at a low ...

Home remedies tend to work best when used alongside medical treatment. It is also important to monitor psoriasis symptoms to ensure the remedies are not worsening them. This article explains what ...

By Dr. Priyom Bose, Ph.D.Reviewed by Benedette Cuffari, M.Sc.Nov 26 2024 New research underscores how air pollution and temperature extremes amplify risks for bronchiectasis patients, pointing to ...